Ramucirumab plus paclitaxel for gastric cancer in China

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	975-976
Number of pages	2
Journal	The Lancet Gastroenterology and Hepatology
Volume	6
Issue number	12
DOIs	https://doi.org/10.1016/S2468-1253(21)00342-3
State	Published - Dec 2021

ASJC Scopus subject areas

@article{36c62821f2c2495db3177acca78c2e15,

title = "Ramucirumab plus paclitaxel for gastric cancer in China",

author = "Yoon, {Harry H.}",

year = "2021",

month = dec,

doi = "10.1016/S2468-1253(21)00342-3",

language = "English (US)",

volume = "6",

pages = "975--976",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Ramucirumab plus paclitaxel for gastric cancer in China

AU - Yoon, Harry H.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85118859743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118859743&partnerID=8YFLogxK

U2 - 10.1016/S2468-1253(21)00342-3

DO - 10.1016/S2468-1253(21)00342-3

M3 - Comment/debate

C2 - 34626551

AN - SCOPUS:85118859743

SN - 2468-1253

VL - 6

SP - 975

EP - 976

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 12

ER -